
Keywords: smri; Aβ; amyloid beta; AD; Alzheimer's disease; APP; amyloid precursor protein; DS; Down syndrome; DTI; diffusion tensor imaging; EEG; electroencephalography; FDG; fluordexoyglucose; NFT; neurofibrillary tangles; PET; positron emission tomography; sMRI; struc